You might also like
Oscar Health, Inc. (OSCR) is a technology-driven health insurance company operating in the United States. The company focuses on providing innovative health insurance solutions for individuals, families, and small businesses. Leveraging its proprietary +Oscar platform, Oscar Health enhances member experiences, improves care coordination, and optimizes operational efficiency.
-
Insurance Products - Offers health insurance plans for individuals, families, and small businesses through federal and state-run healthcare exchanges under the Affordable Care Act (ACA).
- Individual and Small Group Plans - Provides health insurance coverage tailored to individuals, families, and small businesses.
- Cigna+Oscar Partnership - Co-branded health insurance plans targeting small businesses, ending after December 31, 2024.
-
+Oscar Platform Services - Provides administrative and other services to external customers using its proprietary technology platform.
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Mario Schlosser ExecutiveBoard | President of Technology and CTO | None | Co-founder of Oscar Health, transitioned from CEO to President of Technology and CTO on April 3, 2023. | |
Mark T. Bertolini ExecutiveBoard | Chief Executive Officer | Director at Verizon Communications Inc., Thrive Global, and FIDELCO Guide Dog Foundation | Mark T. Bertolini is the CEO of Oscar Health since April 3, 2023, with a background in executive leadership in the healthcare industry. | View Report → |
Alessandrea Quane Executive | Chief Insurance Officer | Board of XL Bermuda, Ltd. | Chief Insurance Officer since March 2021, overseeing insurance operations and contributing to financial performance improvements. | |
Janet Liang Executive | EVP and President of Oscar Insurance | None | Appointed EVP and President of Oscar Insurance, overseeing insurance and operations functions, starting February 24, 2025. | |
R. Scott Blackley Executive | Chief Financial Officer | None | CFO of Oscar Health, with a focus on financial performance improvement, reappointed as CFO on August 14, 2023. | |
Ranmali Bopitiya Executive | Chief Legal Officer | None | Joined Oscar Health in January 2022, overseeing corporate governance, legal, compliance, and government affairs. | |
David Plouffe Board | Director | Board Member of the Obama Foundation | Director since February 2021, with a background in public policy and advocacy. | |
Elbert O. Robinson, Jr. Board | Director | Co-Founder and CEO of Pendulum Holdings LLC; Board Member at Royal Trust Academy and National Museum of African American History and Culture | Director since February 2021, focusing on inclusive growth investing and advisory. | |
Jeffery H. Boyd Board | Chairman of the Board | Managing Director of Compleat Angler Capital, LLC; Board Member at The Home Depot, Inc. and Clear Secure, Inc. | Chairman of the Board since February 2021, with extensive experience in strategic investment and board roles. | |
Joshua Kushner Board | Vice Chairman of the Board | Managing Director of Thrive Capital Management, LLC | Co-founder of Oscar Health, serving as Vice Chairman of the Board since February 2021. | |
Laura Lang Board | Director | Managing Director of Narragansett Ventures, LLC; Adviser to L Catterton; Board Member at V.F. Corporation and Vroom Inc. | Director since December 7, 2022, with a focus on digital business transformation and growth investing. | |
Vanessa A. Wittman Board | Director | Board Member at AIG, Booking Holdings, and Impossible Foods Inc. | Director since February 2021, with extensive experience as CFO of global technology companies. |
-
Your medical loss ratio came in above the high end of guidance due to higher risk adjustment payables; can you quantify the increase and explain what factors are driving this, and how confident are you in your 2025 MLR guidance given these dynamics?
-
With significant growth in SEP membership and expectations of retaining these members, how sustainable is your assumption that their MLRs will improve, and are there any dynamics that might prevent you from seeing the anticipated MLR tailwind in 2025?
-
Your SG&A expense ratio outperformed your previous guidance, implying significant outperformance in the quarter; can you detail what's driving this improvement, specifically whether AI initiatives or other factors are contributing, and are these efficiencies sustainable?
-
Given the concerns around payment integrity and potential changes in effectuation rates due to re-verification programs, how are you addressing the risk of higher-than-expected membership attrition impacting your 2025 revenue projections?
-
As you shift focus from adjusted EBITDA to earnings from operations, can you discuss any material changes to expenses such as interest or stock-based compensation that could impact your operating results, and why you're making this shift now?
Competitors mentioned in the company's latest 10K filing.
| Company | Description |
|---|---|
Part of the peer group selected by the company for performance comparison, indicating it operates in a similar industry, including managed care and healthcare technology companies. | |
Included in the company's peer group for performance comparison, highlighting its relevance as a competitor in the managed care and healthcare technology sectors. | |
Listed as a peer group member for performance comparison, suggesting its competitive presence in healthcare and managed care. | |
Identified as part of the peer group for performance comparison, emphasizing its role as a competitor in the healthcare and managed care industry. | |
Named in the peer group for performance comparison, indicating its competitive position in the healthcare and managed care space. | |
Included in the peer group for performance comparison, reflecting its relevance in the healthcare technology and managed care sectors. | |
Part of the peer group selected for performance comparison, highlighting its competitive role in healthcare technology and managed care. | |
Listed as a peer group member for performance comparison, suggesting its competitive presence in healthcare technology and managed care. | |
Identified in the peer group for performance comparison, emphasizing its role as a competitor in healthcare technology and managed care. | |
Included in the peer group for performance comparison, reflecting its relevance in healthcare technology and managed care. | |
Named in the peer group for performance comparison, indicating its competitive position in healthcare technology and managed care. | |
Local Blue Cross plans | Identified as principal competitors in the individual market, particularly in offering health plans. |
National carriers | Recognized as principal competitors in the individual market, competing in health plan offerings. |
Regional carriers | Listed as principal competitors in the individual market, emphasizing their role in health plan competition. |
Medicaid-focused insurers offering Health Insurance Marketplace products | Highlighted as principal competitors in the individual market, particularly in the context of Medicaid and marketplace products. |
| Customer | Relationship | Segment | Details |
|---|---|---|---|
Centers for Medicare & Medicaid Services (CMS) | Primary payor providing advanced premium tax credits | All | $9,512.3 million in 2024, representing ~92% of direct policy premiums |
No recent press releases or 8-K filings found for OSCR.